ORTEXORTEX News
Tracking 520021? Get live short interest, options flow, and signals on ORTEX.Sign up free →
52
Trader Note520021

Omax Autos races into earnings on a 36% monthly rally

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 3 min readdata as of 30 Apr 2026, 10:56

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Omax Autos Limited heads into its Q4 2026 results — due May 2 — after one of the sharpest pre-earnings runs the stock has seen in years.

The price move is the lead. Shares closed at ₹131.9 on April 29, up 16% on the week and 36% over the past month. That puts the BSE-listed auto components maker firmly in momentum territory, with the RSI14 reading at 71.5 — above the conventional overbought threshold of 70. The stock has now recovered sharply from the ₹85–100 range where it spent much of late 2025 and early 2026, and the Q4 announcement appears to be the magnet pulling it higher.

The earnings history adds context — and a note of caution about extrapolating the recent pattern. A January 27 event produced a remarkable 27% single-day move and held most of those gains over five trading days. The prior report on February 6 delivered only a 2.7% day-one pop, which fully reversed to minus 2.6% by day five. That asymmetry suggests the stock reacts powerfully to positive surprises but gives back ground quickly when the print is merely in line. With the share price already up more than a third in a month, the bar for a further positive reaction is materially higher than it was in January.

Ownership tells the deeper story here. The Mehta family group — founder Jatender Mehta (12.1%), Ravinder Mehta (8.4%), Vivek Mehta (7.6%), and associated entities — holds a combined stake well above 30%. Forerunner Capital Investments, a family holding vehicle, controls another 19.6%, having added roughly 99,800 shares in December 2025 at around ₹100. That buying now looks well-timed. On the other side, Ravinder Mehta sold shares across multiple tranches in May and September 2025, at prices ranging from ₹86 to ₹150, reducing his position incrementally throughout the year. The insider data is dated (latest recorded trade: December 2025), so no fresh signal is available for this week's setup — but the overall picture is of a stock with tightly concentrated promoter control and a family that has been trimming on strength.

No analyst coverage is available in ORTEX data for 520021, consistent with its micro-cap profile — market capitalisation sits near $27 million. That absence of institutional research is itself meaningful: price discovery for a stock this small tends to happen through order flow and earnings events rather than analyst revisions or target-price changes. The sector score of 50 is neutral, and the dividend score of 20 is weak, reflecting a dividend history that goes back only to 2016 and has been dormant since. The EV figure in the data implies the market is ascribing most of the enterprise value to operating assets rather than any cash premium.

Among correlated BSE peers, ASAL was the notable mover, up 6.7% on the week. Most other names in the peer cluster — SONACOMS, SELLOWRAP, and TOLINS — posted modest weekly changes of 1–2%, while AUTOIND slipped nearly 4%. The outperformance of Omax against this group is pronounced, suggesting stock-specific momentum rather than a sector-wide re-rating.

The next focal point is the May 2 result. The question is whether underlying Q4 numbers — on revenue, margins, and any commentary on the two-wheeler and passenger vehicle supply chain — can justify a share price that has already priced in a strong quarter.

Stocks in this article

See the live data behind this article on ORTEX.

Open 520021 on ORTEX →

How this article was generated

Generated
30 Apr 2026, 10:57
Data as of
30 Apr 2026, 10:56
Prompt version
v1.0
Data sources
Earnings
Validation notes
  • soft: missing section mentions: short interest (informational only)

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.